Wee Joo Chng
- Molecular Biology top 0.5%
- Hematology top 0.1%
- Oncology top 0.5%
- Immunology top 1%
- Cancer Research top 1%
- Co-authors
- Jianbiao ZhouRafaël FonsecaSiok‐Bian NgChonglei BiPhaik Ju TeohTae‐Hoon ChungP. Leif BergsagelSanjay De Mel
- Topics
- Multiple Myeloma Research and Treatments (160 papers)Protein Degradation and Inhibitors (93 papers)Lymphoma Diagnosis and Treatment (40 papers)
- Cited by
- HematologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Wee Joo Chng
359 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Molecular Biology 7.2k
- Hematology 4.0k
- Oncology 3.6k
- Immunology 1.6k
- Cancer Research 1.6k
Countries citing papers authored by Wee Joo Chng
This map shows the geographic impact of Wee Joo Chng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wee Joo Chng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wee Joo Chng more than expected).
Fields of papers citing papers by Wee Joo Chng
This network shows the impact of papers produced by Wee Joo Chng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wee Joo Chng. The network helps show where Wee Joo Chng may publish in the future.
Co-authorship network of co-authors of Wee Joo Chng
This figure shows the co-authorship network connecting the top 25 collaborators of Wee Joo Chng. A scholar is included among the top collaborators of Wee Joo Chng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wee Joo Chng. Wee Joo Chng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 37 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 0 | |
| 14 | 11 | |
| 15 | 12 | |
| 16 | 30 | |
| 17 | 41 | |
| 18 | 28 | |
| 19 | 159 | |
| 20 | 195 |
About Wee Joo Chng
Wee Joo Chng is a scholar working on Hematology, Genetics and Oncology, having authored 386 papers that have together received 11.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (160 papers), Protein Degradation and Inhibitors (93 papers) and Lymphoma Diagnosis and Treatment (40 papers). The work is most often cited by research in Hematology (4.0k citations), Oncology (3.6k citations) and Cancer Research (1.6k citations). Wee Joo Chng has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Jianbiao Zhou, Rafaël Fonseca, Siok‐Bian Ng, Chonglei Bi, Phaik Ju Teoh, Tae‐Hoon Chung, P. Leif Bergsagel, Sanjay De Mel, Angela Dispenzieri and Qiang Yu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.